Literature DB >> 26936379

Hepatitis A virus-encoded miRNAs attenuate the accumulation of viral genomic RNAs in infected cells.

Jiandong Shi1,2, Jing Sun1,2, Meini Wu1,2, Ningzhu Hu1,2, Yunzhang Hu3,4.   

Abstract

The establishment of persistent infection with hepatitis A virus (HAV) is the common result of most HAV/cell culture systems. Previous observations show that the synthesis of viral RNAs is reduced during infection. However, the underlying mechanism is poorly understood. We characterized three HAV-encoded miRNAs in our previous study. In this study, we aim to investigate the impact of these miRNAs on the accumulation of viral RNAs. The results indicated that the synthesis of viral genomic RNAs was dramatically reduced (more than 75 % reduction, P < 0.05) when transfected with one or two viral miRNA mimics. Conversely, they were significantly increased (more than 3.3-fold addition, P < 0.05) when transfected with one or two viral miRNA inhibitors. The luciferase reporter assay of miRNA targets showed that viral miRNAs were fully complementary to specific sites of the viral plus or minus strand RNA and strongly inhibited their expressions. Further data showed that the relative abundance of viral genomic RNA fragments that contain miRNA targets was also dramatically reduced (more than 80 % reduction, P < 0.05) when viral miRNAs were overexpressed with miRNA mimics. In contrast, they were significantly increased (approximately 2-fold addition, P < 0.05) when viral miRNAs were inhibited with miRNA inhibitors. In conclusion, these data suggest a possible mechanism for the reduction of viral RNA synthesis during HAV infection. Thus, we propose that it is likely that RNA virus-derived miRNA could serve as a self-mediated feedback regulator during infection.

Entities:  

Keywords:  Genomic RNA; Hepatitis A virus; Viral RNA; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26936379     DOI: 10.1007/s11262-016-1306-1

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  48 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 3.  Hepatitis A virus: from discovery to vaccines.

Authors:  Annette Martin; Stanley M Lemon
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

4.  MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated.

Authors:  Seahyoung Lee; Eunhyun Choi; Sung-Man Kim; Ki-Chul Hwang
Journal:  World J Biol Chem       Date:  2015-05-26

5.  siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus.

Authors:  Padmanava Behera; Shanmugasundaram Nagarajan; Harshad V Murugkar; Semmannan Kalaiyarasu; Anil Prakash; Ragini Gothalwal; Shiv Chandra Dubey; Diwakar D Kulkarni; Chakradhar Tosh
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

6.  Chronic hepatitis A with persistent viral replication.

Authors:  K Inoue; M Yoshiba; H Yotsuyanagi; T Otsuka; K Sekiyama; R Fujita
Journal:  J Med Virol       Date:  1996-12       Impact factor: 2.327

7.  Persistent infection of human fibroblasts by hepatitis A virus.

Authors:  A Vallbracht; L Hofmann; K G Wurster; B Flehmig
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

8.  Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells.

Authors:  S P Day; P Murphy; E A Brown; S M Lemon
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.

Authors:  Dong Kang; Rebecca L Skalsky; Bryan R Cullen
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

10.  Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.

Authors:  Emily P Thi; Chad E Mire; Amy C H Lee; Joan B Geisbert; Joy Z Zhou; Krystle N Agans; Nicholas M Snead; Daniel J Deer; Trisha R Barnard; Karla A Fenton; Ian MacLachlan; Thomas W Geisbert
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.